President Donald Trump has nominated Dr. Casey Means, a physician and health tech entrepreneur, as the next U.S. Surgeon General. The announcement, made Wednesday, highlights Means' alignment with Health Secretary Robert F. Kennedy Jr.’s "Make America Healthy Again" initiative.
Dr. Means, 37, co-founded the health technology company Levels, which uses data from continuous glucose monitors to help users understand how their food choices affect metabolic health. She is a strong advocate for using personalized data to drive healthier lifestyles and is widely seen as a rising voice in the preventive health and biohacking movement.
Her brother, Calley Means, was recently appointed as a White House adviser, focusing on food policy reform and addressing corporate influence on national health trends. Together, the Means siblings have been vocal supporters of reshaping American health through nutrition-focused and tech-driven approaches.
Dr. Means will replace Trump’s previous nominee, Dr. Janette Nesheiwat, who the president announced will now serve in a different senior role within the Department of Health and Human Services alongside Secretary Kennedy.
As Surgeon General, Dr. Means would become the nation’s leading spokesperson on public health, responsible for delivering science-based guidance on disease prevention, wellness, and reducing chronic illness. Her nomination is expected to energize health reform advocates who support lifestyle medicine and digital health innovation.
Trump’s pick signals a continued shift toward preventive care and a broader embrace of alternative health strategies that prioritize nutrition, metabolic awareness, and data-driven wellness tools. The nomination must still be confirmed by the Senate.


Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades
Trump Proposes Two-Year Shutdown of Kennedy Center Amid Ongoing Turmoil
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccines Portfolio
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Syria Detains Group Over Rocket Attacks on Damascus Military Airport Amid Hezbollah Allegations
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China as Competition Intensifies
Novo Nordisk Launches Once-Daily Wegovy Pill in U.S. at Competitive Pricing
Pierre Poilievre Retains Conservative Leadership After Election Defeat in Canada
U.S. Government Faces Brief Shutdown as Congress Delays Funding Deal
Trump Orders DHS to Avoid Protests in Democratic Cities Unless Federal Assets Are Threatened
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
U.S. and Israeli Military Leaders Hold Pentagon Talks as Tensions With Iran Escalate 



